TipRanks
Celldex Therapeutics Inc (DE:TCE2)
FRANKFURT:TCE2
Germany Market

Celldex (TCE2) Cash flow

4 Followers

Celldex Cash Flow

DE:TCE2's free cash flow for Q2 2026 was $-60.59M. For the 2026 fiscal year, DE:TCE2's free cash flow was decreased by $-53.96M and operating cash flow was $-57.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -210.94M$ -157.78M$ -107.29M$ -103.73M$ -60.91M
Investing Cash Flow
$ 209.07M$ -290.13M$ -105.78M$ 89.94M$ -216.16M
Financing Cash Flow
$ 2.39M$ 441.45M$ 218.46M$ 4.08M$ 272.37M
End Cash Position
$ 28.87M$ 28.36M$ 34.81M$ 29.43M$ 39.14M
Free Cash Flow
$ -213.66M$ -159.70M$ -109.11M$ -105.56M$ -62.16M
Currency in USD

Celldex Cash Flow